This story is a follow up the the one I had posted a few days about Vioxx/this issue of ghostwriting.
"The Food and Drug Administration has been considering a proposal to let drug makers use reprints of journal articles in promoting drugs for so-called off-label uses the F.D.A. itself has not approved. A main proviso of the proposal is that the articles must have been published in peer-reviewed medical journals."
Sunday, April 20, 2008
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment